TSXV:CLAS.H - Post by User
Post by
MiSdyngNASTYon May 25, 2020 8:01am
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
139 Views
Post# 31067893
Kalytera Defaults on GVHD Program
Kalytera Defaults on GVHD ProgramNo revenue. Can't pay debts up to 100m now. Defaulting on GVHD program. Will lose it back to Talent. Begging for a new "acquisition". You all got played again. Same old scam shell company Kalytera. Kalytera acquired its GVHD program through the acquisition of Talent Biotechs Ltd. (Talent) in 2017. Kalyteras subsidiary, Kalytera Therapeutics Israel Ltd. (Kalytera Israel) owns the assets of the GVHD program, and is in default under a Promissory Note evidencing a USD $3 million debt that is owed by Kalytera Israel to the former shareholders of Talent